Artelo Biosciences (ARTL) Short Interest Ratio & Short Volume $1.00 +0.02 (+2.04%) As of 02:12 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock Artelo Biosciences Short Interest DataArtelo Biosciences (ARTL) has a short interest of 874,800 shares, representing 26.92% of the float (the number of shares available for trading by the public). This marks a 58,220.00% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.2, indicating that it would take 2.2 days of the average trading volume of 317,050 shares to cover all short positions.Current Short Interest874,800 sharesPrevious Short Interest1,500 sharesChange Vs. Previous Month+58,220.00%Dollar Volume Sold Short$901,044.00Short Interest Ratio2.2 Days to CoverLast Record DateApril 15, 2025Outstanding Shares3,281,000 sharesFloat Size3,250,000 sharesShort Percent of Float26.92%Today's Trading Volume52,068 sharesAverage Trading Volume317,050 sharesToday's Volume Vs. Average16% Short Selling Artelo Biosciences? Sign up to receive the latest short interest report for Artelo Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartARTL Short Interest Over TimeARTL Days to Cover Over TimeARTL Percentage of Float Shorted Over Time Artelo Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2025874,800 shares $901,044.00 +58,220.0%26.9%2.2 $1.03 3/31/20251,500 shares $1,312.50 +7.1%0.1%0.1 $0.88 3/15/20251,400 shares $1,344.00 +16.7%0.0%0.1 $0.96 2/28/20251,200 shares $1,284.00 -91.0%0.0%0 $1.07 2/15/202513,400 shares $15,946.00 +55.8%0.4%0.4 $1.19 1/31/20258,600 shares $10,371.60 -41.1%0.3%0.2 $1.21 1/15/202514,600 shares $16,936.00 -21.5%0.5%0.5 $1.16 12/31/202418,600 shares $19,716.00 -42.2%0.6%0.6 $1.06 12/15/202432,200 shares $35,742.00 -2.1%1.0%1.2 $1.11 11/30/202432,900 shares $34,545.00 +51.6%1.0%1.3 $1.05 Get the Latest News and Ratings for ARTL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Artelo Biosciences and its competitors with MarketBeat's FREE daily newsletter. 11/15/202421,700 shares $22,785.00 +9.1%0.7%1.3 $1.05 10/31/202419,900 shares $23,681.00 -26.8%0.6%1.8 $1.19 10/15/202427,200 shares $29,920.00 -18.3%0.9%3 $1.10 9/30/202433,300 shares $37,302.66 -8.3%1.0%0.4 $1.12 9/15/202436,300 shares $42,834.00 -20.7%1.1%0.5 $1.18 8/31/202445,800 shares $59,540.00 +22.8%1.4%0.6 $1.30 8/15/202437,300 shares $48,490.00 -20.5%1.2%0.5 $1.30 7/31/202446,900 shares $63,315.00 +3,808.3%1.5%0.6 $1.35 7/15/20241,200 shares $1,596.00 -91.5%0.0%0 $1.33 6/30/202414,100 shares $18,894.00 +2.9%0.4%1.2 $1.34 6/15/202413,700 shares $18,769.00 +39.8%0.4%1.2 $1.37 5/31/20249,800 shares $13,426.00 +58.1%0.3%0.7 $1.37 5/15/20246,200 shares $8,184.62 +26.5%0.2%0.4 $1.32 4/30/20244,900 shares $6,739.95 -19.7%0.2%0.3 $1.38 4/15/20246,100 shares $9,028.00 -57.9%0.2%0.4 $1.48 3/31/202414,500 shares $21,460.00 -28.2%0.5%0.9 $1.48 3/15/202420,200 shares $29,088.00 +9.2%0.6%1.1 $1.44 2/29/202418,500 shares $28,305.00 +117.7%0.6%1.1 $1.53 2/15/20248,500 shares $14,705.00 -38.9%0.3%0.5 $1.73 1/31/202413,900 shares $19,460.00 -3.5%0.4%0.8 $1.40 1/15/202414,400 shares $21,024.00 -0.7%0.5%0.7 $1.46 12/31/202314,500 shares $20,300.00 -44.9%0.5%0.5 $1.40 12/15/202326,300 shares $35,505.00 -18.1%0.8%0.9 $1.35 11/30/202332,100 shares $45,582.00 +9.9%1.0%0.9 $1.42 11/15/202329,200 shares $37,668.00 +3.6%0.9%0.1 $1.29 10/31/202328,200 shares $34,827.00 -56.4%1.0%0.1 $1.24 10/15/202364,700 shares $92,521.00 +34.8%2.3%0.2 $1.43 9/30/202348,000 shares $70,080.00 -42.7%1.7%0.2 $1.46 9/15/202383,800 shares $128,214.00 +357.9%2.9%0.3 $1.53 8/31/202318,300 shares $34,404.00 +8.9%0.6%0.1 $1.88Musk's warning signal: Prepare before the cascade begins (Ad)When Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t. With 40+ years of market modeling, he says Musk’s move wasn’t about efficiency — it was a signal. And what’s coming next could divide the market into winners and losers faster than anyone expects. Watch this urgent video briefing now.Watch the Musk market warning before the dominoes fall 8/15/202316,800 shares $33,768.00 -21.9%0.6%1.3 $2.01 7/31/202321,500 shares $41,065.00 -16.7%0.8%1.7 $1.91 7/15/202325,800 shares $51,084.00 -21.8%0.9%1.4 $1.98 6/30/202333,000 shares $66,330.00 +4.4%1.2%1.8 $2.01 6/15/202331,600 shares $64,464.00 +10.5%1.1%1.5 $2.04 5/31/202328,600 shares $51,079.60 +6.7%1.0%1.4 $1.79 5/15/202326,800 shares $45,828.00 +48.9%1.0%1.3 $1.71 4/30/202318,000 shares $29,340.00 -77.3%0.6%0.8 $1.63 4/15/202379,300 shares $206,608.22 +16.3%2.8%4.2 $2.61 3/31/202368,200 shares $158,224.00 +75.3%2.4%3.3 $2.32 3/15/202338,900 shares $89,470.00 -30.3%1.4%1.8 $2.30 2/28/202355,800 shares $159,867.00 -26.0%2.0%2.5 $2.87 2/15/202375,400 shares $226,954.00 +40.2%2.7%3.3 $3.01 1/31/202353,800 shares $173,236.00 -34.5%1.9%2.2 $3.22 1/15/202382,100 shares $267,646.00 -22.9%2.9%3.5 $3.26 12/30/2022106,500 shares $307,785.00 -16.2%3.7%4.8 $2.89 12/15/2022127,100 shares $374,945.00 +37.0%4.5%6.2 $2.95 11/30/202292,800 shares $228,288.00 +4.3%3.3%3.6 $2.46 11/15/202289,000 shares $258,990.00 +11.1%3.1%2.3 $2.91 10/31/202280,100 shares $229,887.00 +11.3%2.8%0.2 $2.87 10/15/202272,000 shares $228,240.00 -4.9%2.5%0.2 $3.17 9/30/202275,700 shares $261,165.00 +30.1%2.7%0.2 $3.45 9/15/202258,200 shares $240,948.00 +39.6%2.1%0.2 $4.14 8/31/202241,700 shares $160,545.00 -33.7%1.5%0.1 $3.85 8/15/202262,900 shares $274,244.00 -91.5%2.2%0.2 $4.36 7/31/2022737,000 shares $250,653.70 -17.1%N/A2.2 $0.34 7/15/2022888,500 shares $302,090.00 -2.4%N/A2.7 $0.34 6/30/2022910,500 shares $288,446.40 +8.0%N/A0.7 $0.32 6/15/2022843,300 shares $266,651.46 -15.7%N/A0.6 $0.32 5/31/20221,000,000 shares $331,000.00 +80.6%N/A0.7 $0.33 5/15/2022553,600 shares $183,241.60 -31.3%N/A0.4 $0.33 4/30/2022806,300 shares $308,006.60 +19.4%N/A0.6 $0.38 4/15/2022675,600 shares $290,508.00 -30.0%N/A0.5 $0.43 3/31/2022964,800 shares $434,160.00 +45.6%N/A1.8 $0.45 3/15/2022662,700 shares $265,080.00 +21.2%N/A1.2 $0.40 2/28/2022546,800 shares $217,243.64 -19.1%N/A0.9 $0.40 2/15/2022675,700 shares $261,901.32 +35.4%N/A0.9 $0.39 1/31/2022499,000 shares $209,580.00 -37.4%N/A0.4 $0.42 1/15/2022797,200 shares $350,768.00 +4.8%N/A0.1 $0.44 12/31/2021760,700 shares $394,803.30 -1.8%N/A0.1 $0.52 12/15/2021774,300 shares $446,848.53 -4.6%N/A0.1 $0.58 11/30/2021811,900 shares $511,497.00 -36.1%N/A0.1 $0.63 11/15/20211,270,000 shares $1.08 million +69.7%N/A0.2 $0.85 10/29/2021748,300 shares $535,782.80 -9.8%N/A0.1 $0.72 10/15/2021829,800 shares $634,797.00 -4.3%N/A2.8 $0.77 9/30/2021866,600 shares $685,047.30 -27.8%N/A2.9 $0.79 9/15/20211,200,000 shares $990,000.00 -2.4%N/A3.5 $0.83 8/31/20211,230,000 shares $1.12 million -13.4%N/A3.1 $0.91 8/13/20211,420,000 shares $1.23 million -13.4%N/A3 $0.87 7/30/20211,640,000 shares $1.64 million -6.8%N/A3.4 $1.00Musk's warning signal: Prepare before the cascade begins (Ad)When Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t. With 40+ years of market modeling, he says Musk’s move wasn’t about efficiency — it was a signal. And what’s coming next could divide the market into winners and losers faster than anyone expects. Watch this urgent video briefing now.Watch the Musk market warning before the dominoes fall 7/15/20211,760,000 shares $1.81 million +4.8%N/A3.7 $1.03 6/30/20211,680,000 shares $2.00 million +0.6%N/A2.7 $1.19 6/15/20211,670,000 shares $1.95 million +3.1%7.6%2.5 $1.17 5/28/20211,620,000 shares $2.01 million -1.8%7.4%1.8 $1.24 5/14/20211,650,000 shares $1.86 million -4.1%N/A1.1 $1.13 4/30/20211,720,000 shares $2.29 million -6.5%N/A0.3 $1.33 4/15/20211,840,000 shares $2.34 million -13.2%N/A0.2 $1.27 3/31/20212,120,000 shares $3.31 million -17.2%N/A0.2 $1.56 3/15/20212,560,000 shares $5.04 million -10.2%N/A0.3 $1.97 2/26/20212,850,000 shares $5.56 million +0.4%N/A0.3 $1.95 2/12/20212,840,000 shares $4.63 million +49.5%N/A0.3 $1.63 1/29/20211,900,000 shares $1.71 million +79.3%N/A0.5 $0.90 1/15/20211,060,000 shares $1.07 million +54.0%N/A0.4 $1.01 12/31/2020688,400 shares $481,122.76 +16.1%N/A0.3 $0.70 12/15/2020592,900 shares $391,314.00 +3.1%N/A0.3 $0.66 11/30/2020575,200 shares $345,120.00 +2.4%N/A0.3 $0.60 11/15/2020562,000 shares $292,296.20 -39.9%N/A0.3 $0.52 10/30/2020934,400 shares $466,732.80 +201.7%N/A0.6 $0.50 10/15/2020309,700 shares $240,884.66 +113.6%N/A0.2 $0.78 9/30/2020145,000 shares $143,927.00 -9.3%N/A0.2 $0.99 9/15/2020159,900 shares $140,712.00 +32.0%4.8%0.3 $0.88 8/31/2020121,100 shares $116,256.00 +76.5%3.6%0.2 $0.96 8/14/202068,600 shares $78,890.00 +127.9%2.1%0.2 $1.15 7/31/202030,100 shares $34,615.00 +30.3%1.0%0.1 $1.15 7/15/202023,100 shares $25,410.00 +266.7%0.8%0.1 $1.10 6/30/20206,300 shares $7,623.00 +26.0%0.3%0 $1.21 6/15/20205,000 shares $6,300.00 -70.9%0.2%0 $1.26 5/29/202017,200 shares $22,016.00 +352.6%0.8%0.1 $1.28 5/15/20203,800 shares $4,180.00 -84.9%0.2%0 $1.10 ARTL Short Interest - Frequently Asked Questions What is Artelo Biosciences' current short interest? Short interest is the volume of Artelo Biosciences shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 874,800 shares of ARTL short. 26.92% of Artelo Biosciences' shares are currently sold short. Learn More on Artelo Biosciences' current short interest. What is a good short interest ratio for Artelo Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ARTL shares currently have a short interest ratio of 2.0. Learn More on Artelo Biosciences's short interest ratio. What is a good short interest percentage for Artelo Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 26.92% of Artelo Biosciences' floating shares are currently sold short. Is Artelo Biosciences' short interest increasing or decreasing? Artelo Biosciences saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 874,800 shares, an increase of 58,220.0% from the previous total of 1,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Artelo Biosciences' float size? Artelo Biosciences currently has issued a total of 3,281,000 shares. Some of Artelo Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Artelo Biosciences currently has a public float of 3,250,000 shares. How does Artelo Biosciences' short interest compare to its competitors? 26.92% of Artelo Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Artelo Biosciences: Cellectar Biosciences, Inc. (4.99%), 23andMe Holding Co. (11.90%), Moleculin Biotech, Inc. (3.32%), Upexi, Inc. (5.92%), Imunon, Inc. (7.33%), ProPhase Labs, Inc. (6.76%), Marker Therapeutics, Inc. (2.64%), MEI Pharma, Inc. (0.07%), ImmunoPrecise Antibodies Ltd. (5.18%), Synlogic, Inc. (0.43%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short Artelo Biosciences stock? Short selling ARTL is an investing strategy that aims to generate trading profit from Artelo Biosciences as its price is falling. ARTL shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Artelo Biosciences? A short squeeze for Artelo Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ARTL, which in turn drives the price of the stock up even further. How often is Artelo Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ARTL, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies CLRB Short Interest Data ME Short Interest Data MBRX Short Interest Data UPXI Short Interest Data IMNN Short Interest Data PRPH Short Interest Data MRKR Short Interest Data MEIP Short Interest Data IPA Short Interest Data SYBX Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ARTL) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Artelo Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Artelo Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ARTL Stock Free ARTL Stock Alerts